Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
American Journal of Clinical Oncology|April 1, 2008
Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancerHaruhito Azuma, Yatsugu Kotake, Kazuhiro Yamamoto, et al.
Molecular Therapy. Methods & Clinical Development|March 27, 2019
Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical TreatmentYuki Yoshikawa, Kohei Taniguchi, Takuya Tsujino, et al.
Contemporary Clinical Trials Communications|February 22, 2021
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter studyYuta Sekino, Hitoshi Ishikawa, Tomokazu Kimura, et al.
Biochemical and Biophysical Research Communications|April 1, 2014
Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosisKiyoshi Takahara, Masaaki Ii, Teruo Inamoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient miceHayahito Nomi, Junko Tashiro-Yamaji, Yumiko Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2016
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expressionKazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara, et al.
Japanese Journal of Clinical Oncology|September 4, 2013
Adverse event profile and dose modification of everolimus for advanced renal cell carcinoma in real-world Japanese clinical practiceMasahiro Nozawa, Norio Nonomura, Takeshi Ueda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2019
Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In VivoTomoaki Takai, Takuya Tsujino, Yuki Yoshikawa, et al.
Current Urology|January 25, 2021
Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database StudyTeruo Inamoto, Hideyasu Matsuyama, Kazumasa Komura, et al.
Oncotarget|January 20, 2018
The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinomaTeruo Inamoto, Hideyasu Matsuyama, Shigeru Sakano, et al.
Pageof 26